Dermatology · Hato Rey, PR
NPI
1538154315
Since 2005
Specialty
Dermatology
Code 207N00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
525 Ave Roosvelet Plaza Las Americas Tower, Suite 712
Hato Rey, PR, 00918
Phone (787) 764-6611
Groups this clinician bills Medicare through
Medicare paid, 2024
$26K
234 services
Medicare patients, 2024
58
Average age 77
Drug cost, 2024
$871K
4,049 prescriptions
Company payments, 2025
$52.89
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Roberto L Davila-Depedro was code 99212 (office e&m - established), 30 times for 17 patients. In total Roberto L Davila-Depedro billed 234 services in 38 codes, and Medicare paid $26K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-04-13.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99212 Office E&M - Established | Office | 30 | 17 | $34.58 | $1,038 |
| 11406 Skin Lesion Excision | Office | 23 | 12 | $196.15 | $4,511 |
| 99202 Office E&M - New | Office | 18 | 18 | $34.56 | $622 |
| 17004 Destruction Skin Lesion | Office | 16 | 13 | $84.39 | $1,350 |
By year: 2022 $26K for 247 services; 2023 $27K for 260 services; 2024 $26K for 234 services.
Medicare prescription drug claims, 2024
In 2024, the drug Roberto L Davila-Depedro prescribed most often to Medicare patients was Gentamicin Sulfate, with 1,096 prescriptions and refills. In total Roberto L Davila-Depedro wrote 4,049 Medicare prescriptions that cost $871K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Gentamicin Sulfate Generic | 1,096 | 1,096 | 595 | $48K |
| Cephalexin Generic | 549 | 549 | 379 | $3,901 |
| Mupirocin Generic | 425 | 425 | 279 | $4,018 |
| Ketoconazole Generic | 362 | 373 | 219 | $7,548 |
| Clotrimazole Generic | 329 | 329 | 183 | $3,666 |
| Betamethasone Diprop Augmented Betamethasone/Propylene Glyc | 247 | 247 | 140 | $2,366 |
| Terbinafine Hcl Generic | 216 | 216 | 95 | $2,994 |
| Calcipotriene Generic | 206 | 210 | 119 | $31K |
| Ciprofloxacin Hcl Generic | 77 | 77 | 48 | $535 |
| Hydroxyzine Hcl Generic | 75 | 75 | 47 | $397 |
| Prednisone Generic | 50 | 50 | 41 | $306 |
| Triamcinolone Acetonide Generic | 45 | 45 | 24 | $509 |
| Betamethasone Dipropionate Generic | 37 | 37 | 25 | $1,180 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 27 | 27 | 17 | $133 |
| Hydrocortisone Generic | 26 | 26 | 23 | $250 |
Brand drugs: 204 claims; generic drugs: 3,845 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Roberto L Davila-Depedro $52.89 ($52.89 in general payments such as food, travel and fees) from 2 companies. The largest payer was Revance Therapeutics, Inc. with $28.82.
| Company | Payments | Amount |
|---|---|---|
| Revance Therapeutics, Inc. | 1 | $28.82 |
| Abbvie Inc. ABBV | 1 | $24.07 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.